Exploring the Epidemiology of Hospital-Acquired Bloodstream Infections in Children in England (January 2009–March 2010) by Linkage of National Hospital Admissions and Microbiological Databases
Author(s) -
Ruth Blackburn,
Katherine L. Henderson,
Mehdi Minaji,
Berit MüllerPebody,
Alan P. Johnson,
Mike Sharland
Publication year - 2012
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/pis084
Subject(s) - medicine , meropenem , penicillin , bacteremia , vancomycin , tazobactam , antibiotics , antibiotic resistance , piperacillin , pediatrics , drug resistance , imipenem , staphylococcus aureus , microbiology and biotechnology , pseudomonas aeruginosa , bacteria , biology , genetics
Hospital-acquired bloodstream infection (HA-BSI) requires immediate effective antibiotic treatment. However, there are no published national data for England that describe the pathogen profile and antibiotic resistance rates of HA-BSI in children.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom